Divergent immunobiological correlates of FDA-/EMA-approved PD-L1 assays and scoring algorithms in muscle-invasive bladder cancer

Weyerer, V. and Geppert, C. and Bertz, S. and Taubert, H. and Breyer, J. and Bolenz, C. and Erben, P. and Wach, S. and Sikic, D. and Kunath, F. and Wullich, B. and Hartmann, A. and Eckstein, M. (2020) Divergent immunobiological correlates of FDA-/EMA-approved PD-L1 assays and scoring algorithms in muscle-invasive bladder cancer. In: International Bladder Cancer Network (IBCN), October 17, 2020.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Petra Gürster
Date Deposited: 21 Apr 2021 10:14
Last Modified: 21 Apr 2021 10:14
URI: https://pred.uni-regensburg.de/id/eprint/43256

Actions (login required)

View Item View Item